CYP4F3
CYP4F3 is a gene in humans that encodes the CYP4F3 enzyme, a member of the cytochrome P450 superfamily of enzymes. The proteins encoded by these enzymes are involved in the oxidation of organic substances and play a critical role in the metabolism of drugs and the synthesis of cholesterol, steroids, and other lipids.
Function[edit]
The CYP4F3 enzyme is primarily involved in the metabolism of leukotriene B4 (LTB4), a potent inflammatory mediator. This enzyme is also involved in the metabolism of certain fatty acids, contributing to the regulation of lipid metabolism in the body. The CYP4F3 enzyme is expressed in various tissues, with significant expression in the liver and leukocytes, indicating its importance in both systemic and localized metabolic processes.
Genetic Variants[edit]
Variants of the CYP4F3 gene have been studied in the context of their potential impact on drug metabolism and susceptibility to diseases. Genetic polymorphisms in CYP4F3 can affect enzyme activity and, consequently, the metabolism of LTB4 and other substrates. This variability can influence individual responses to drugs and susceptibility to conditions characterized by inflammation or altered lipid metabolism.
Clinical Significance[edit]
The role of CYP4F3 in metabolizing inflammatory mediators like LTB4 links it to inflammatory diseases. Inhibitors of the CYP4F3 enzyme are being explored as potential therapeutic agents for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cardiovascular diseases, where inflammation plays a key role in disease progression.
Research Directions[edit]
Research on CYP4F3 continues to explore its broader role in lipid metabolism and the potential therapeutic applications of modulating its activity. Understanding the genetic and environmental factors that influence CYP4F3 activity could lead to personalized medicine approaches for treating diseases associated with inflammation and lipid metabolism disorders.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
